C12N 2760/16051
Methods of production or purification of viral material
C12N2760/16051 (Methods of production or purification of viral material) appears on 100 US grants and 154 published applications in this corpus.
Search patents in C12N- Granted patents
- 100
- Published applications
- 154
- Assignees
- 100
- Inventors
- 239
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 1 | 4 |
| 2006 | 2 | 5 |
| 2007 | 4 | 5 |
| 2008 | 2 | 4 |
| 2009 | 1 | 8 |
| 2010 | 2 | 13 |
| 2011 | 5 | 10 |
| 2012 | 9 | 11 |
| 2013 | 5 | 8 |
| 2014 | 6 | 5 |
| 2015 | 9 | 9 |
| 2016 | 6 | 18 |
| 2017 | 5 | 5 |
| 2018 | 6 | 10 |
| 2019 | 6 | 10 |
| 2020 | 7 | 5 |
| 2021 | 9 | 6 |
| 2022 | 3 | 4 |
| 2023 | 4 | 2 |
| 2024 | 3 | 5 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production30 Jun 2026US 12,667,612 B2Fujifilm Biosciences Inc.
- Preparation of influenza virus vaccine antigens3 Jun 2025US 12,318,442 B2Seqirus UK Limited
- Recombinant influenza viruses with stabilized HA for replication in eggs18 Mar 2025US 12,251,436 B2The University of Tokyo
- Production of viruses in cell culture6 Aug 2024US 12,054,750 B2Commonwealth Scientific and Industrial Research Organisation
- Engineered influenza antigenic polypeptides and immunogenic compositions thereof16 Jul 2024US 12,037,364 B2Sanofi Pasteur Limited
- Preparation of influenza virus vaccine antigens19 Feb 2026US 2026/0048115 A1Seqirus UK Limited
- Recombinant influenza viruses with stabilized ha for replication in eggs14 Aug 2025US 2025/0255953 A1The University of Tokyo
- Production of viruses in cell culture9 Jan 2025US 2025/0011731 A1Commonwealth Scientific and Industrial Research Organisation
- A vaccine for coronavirus and influenza virus, and method for preparation thereof5 Dec 2024US 2024/0398930 A1Bharat Biotech International Limited
- Vaccine compositions and methods of use thereof16 May 2024US 2024/0156948 A1Excepgen Inc.
Most cited
By later US patents
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Methods for producing preparations of recombinant AAV virions substantially free of empty capsids69US 8,137,948 B2Genzyme Corporation · 2012
- Recombinant negative strand RNA virus expression systems and vaccines47US 6,887,699 B1MedImmune Vaccines, Inc. · 2005
- Recombinant influenza vectors with tandem transcription units41US 7,968,101 B2Wisconsin Alumni Research Foundation · 2011
- Methods for producing preparations of recombinant AAV virions substantially free of empty capsids35US 9,528,126 B2Genzyme Corporation · 2016